Appearance of TSH receptor antibody and hyperthyroidism associated with metastatic thyroid cancer after total thyroidectomy

Endocrine Journal

Volumn 44, Issue 6, 1997, Pages 855-859

  Yoshimura Noh, Jaeduk ^a   Mimura, Takashi ^a   Kawano, Michikazu ^a   Hamada, Noboru ^b   Ito, Kunihiko ^a  

^a ITO HOSPITAL   (Japan)

^b Sumire Hospital   (Japan)

Author keywords

Follicular carcinoma; Hyperthyroidism; Thyrotoxicosis; TSH receptor antibody

Indexed keywords

ANTITHYROID AGENT; DEXAMETHASONE; IMMUNOGLOBULIN; IODINE 131; LEVOTHYROXINE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; HUMAN; HYPERTHYROIDISM; MALE; METASTASIS; NECK DISSECTION; RADIOISOTOPE THERAPY; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; THYROTOXICOSIS;

EID: 0031428169     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.855     Document Type: Article

References (26)

1. Frantz VK, Ball PR, Keston SA, Palmer WW (1944) Thyroid carcinoma with metastases: Studied with radioactive iodine. Ann Surg 119: 668-689.
2. Ginsburg E, Catz B, Nelson LC, Kozikowski MB, Chesne LE (1963) Hyperthyroidism secondary to metastatic functioning thyroid carcinoma. Ann Intern Med 58: 684-690.
3. Federman DD (1964) Hyperthyroidism due to functioning metastatic carcinoma of the thyroid. Medicine 43: 267-274.
4. Dorta T, Lemarchand-Beraud T, Burri C (1968) Ein Fall von Schilddrusenkarzinom mit hyper-funktionierenden Metastasen. Schweiz Med Wochenschr 98: 701-704.
5. Sussman L, Librik L, Clayton WG (1968) Hyperthyroidism attributable to a hyperfunctioning thyroid carcinoma. J Pediatr 72: 208-213.
6. Valenta L, Lemarchand-Beraud T, Nemec J, Griessen M, Bednar J (1969) Metastatic thyroid carcinoma provoking hyperthyroidism, with elevated circulating thyrostimulators. Am J Med 48: 72-76.
7. McLaughlin PR, Scholz AD, McConahey MW, Childs SD Jr (1970) Metastatic thyroid carcinoma with hyperthyroidism: Two cases with functioning metastatic follicular thyroid carcinoma. Mayo Clin Proc 45: 328-335.
8. Ghose KM, Genuth MS, Abellera RM, Friedman S, Lidsky I (1971) Functioning primary thyroid carcinoma and metastases producing hyperthyroidism. J Clin Endocrinol 33: 639-646.
9. McConnon KJ, Westarp VC, Mitchell IR (1975) Follicular carcinoma of the thyroid with functioning metastases and clinical hyperthyroidism. Can Med Assoc J 112: 724-727.
10. Aiyoshi Y, Ogata E (1978) Report on a case of functioning thyroid carcinoma provoking thyrotoxicosis with review of literature. Endocrinol Japon 25: 623-629.
11. Snow MH, Davies T, Smith BR, Ross WM, Evans RGB, Teng CS, Hall R (1979) Thyroid stimulating antibodies and metastatic thyroid carcinoma. Clin Endocrinol 10: 413-418.
12. Nakashima T, Inoue K, Shiro-ozu A, Yoshinari M, Okamura K, Itoh M (1981) Predominant T3 synthesis in the metastatic thyroid carcinoma in a patient with T3-toxicosis. Metabolism 30: 327-330.
13. Kruter HER, Liedtke M, Castro DE JAS, Gross JL (1981) T3 hyperthyroidism and thyroid cancer. Clin Endocrinol 16: 121-125.
14. Yeo PPB, WANG KW, Sinniah R, Chang CH, Sethi VK, Tan BC, Lim P (1982) Thyrotoxicosis and thyroid cancer. Aust N Z Med 12: 589-593.
15. Pont A, Spratt D, Shinn BJ (1982) T3 toxicosis due to nonmetastatic follicular carcinoma of the thyroid. West J Med 136: 255-258.
16. Chapman CN, Sziklas JJ, Spencer RP, Bower BF, Rosenberg RJ (1984) Hyperthyroidism with metastatic follicular thyroid carcinoma. J Nucl Med 25: 466-468.
17. Bowden DCW, Jones EMR (1986) Thyrotoxicosis associated with distant metastatic follicular carcinoma of the thyroid. South Med J 79: 483-486.
18. Filetti S, Belfiore A, Amir MS, Daniels HG, Ippolito O, Vigneri R, Ingbar HS (1988) The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 318: 753-759.
19. Girelli ME, Casara D, Rubello D, Pelizzo MR, Busnardo B, Ziliotto D (1990) Severe hyperthyroidism due to metastatic papillary thyroid carcinoma with favorable outcome. J Endocrinol Invest 13: 333-337.
20. Kasagi K, Takeuchi R, Miyamoto S, Misaki T, Inoue D, Shimazu A, Mori T, Konishi J (1994) Metastatic thyroid cancer presenting as thyrotoxicosis: Report of three cases. Clin Endocrinol 40: 429-434.
21. Kasagi K, Konishi J, Arai K (1986) A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. J Clin Endocrinol Metab 62: 855-862.
22. Sung CL, Cavalieri RR (1973) T3 thyrotoxicosis due to metastatic thyroid carcinoma. J Clin Endocrinol Metab 36: 215-217.
23. Cerletty MJ, Listwan JW (1979) Hyperthyroidism due to functioning metastatic thyroid carcinoma. JAMA 242: 269-270.
24. Schorr I, Hinshaw HT, Cooper MA, Mahaffee D, Ney RL (1972) Adenyl cyclase hormone responses certain human endocrine tumors. J Clin Endocrinol 34: 441-451.
25. Black BM, Woolner BL, Blackburn MC (1953) The uptake of radioactive iodine by carcinoma of the thyroid gland: A study of 128 cases. J Clin Endocrinol 13: 1378-1390.
26. Steffensen FH, Aunsholt NA (1994) Hyperthyroidism associated with metastatic thyroid carcinoma. Clin Endocrinol 41: 685-687.